Featured

Latest News

Market Exclusive Biotech News & Analysis

The Intercept Pharmaceuticals Inc (NASDAQ:ICPT) Looks Like An Opportunity

Towards the end of last week, $1.5 billion market capitalization biotechnology company Intercept Pharmaceuticals Inc (NASDAQ:ICPT) reported that the US Food And Drug Administration...
Run

Biotech Movers: Versartis, Inc. (NASDAQ:VSAR) and Intercept Pharmaceuticals Inc (NASDAQ:ICPT)

It has been a tough close to the week for a number of biotech companies. Disappointing clinical trial data, as well as some unexpected...